Unknown

Dataset Information

0

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma.


ABSTRACT: The aggressiveness of mismatch repair (MMR) deficient endometrial carcinomas was examined in a single institution retrospective study. Outcomes were similar for MMR proficient (n = 508) and deficient (n = 287) carcinomas, identified by immunohistochemistry. In accordance with molecular classification based on The Cancer Genome Atlas (TCGA), tumors with abnormal p53 staining or polymerase-ϵ exonuclease domain mutation were excluded from the MMR proficient subgroup, termed as "no specific molecular profile" (NSMP). Compared with NSMP (n = 218), MMR deficiency (n = 191) was associated with poor disease-specific survival (p = 0.001). MMR deficiency was associated with an increased risk of cancer-related death when controlling for confounders (hazard ratio 2.0). In the absence of established clinicopathologic risk factors, MMR deficiency was invariably associated with an increased risk of cancer-related death in univariable analyses (hazard ratios ≥ 2.0). In contrast, outcomes for MMR deficient and NSMP subgroups did not differ when risk factors were present. Lymphatic dissemination was more common (p = 0.008) and the proportion of pelvic relapses was higher (p = 0.029) in the MMR deficient subgroup. Our findings emphasize the need for improved triage to adjuvant therapy and new therapeutic approaches in MMR deficient endometrial carcinomas.

SUBMITTER: Loukovaara M 

PROVIDER: S-EPMC8268938 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5523547 | biostudies-literature
| S-EPMC7830023 | biostudies-literature
| S-EPMC7302890 | biostudies-literature
| S-EPMC8141969 | biostudies-literature
| S-EPMC6649738 | biostudies-literature
| S-EPMC1867211 | biostudies-literature
| S-EPMC6283658 | biostudies-other
| S-EPMC8418420 | biostudies-literature
| S-EPMC8550932 | biostudies-literature
2022-10-07 | GSE212217 | GEO